RED
BANK, N.J., April 28,
2022 /PRNewswire/ -- Provention Bio, Inc. (Nasdaq:
PRVB), a biopharmaceutical company dedicated to intercepting and
preventing immune-mediated disease, today announced that it will
report its first quarter 2022 financial results on Thursday, May 5, 2022, before the opening of the
U.S. financial markets. Subsequently, at 8:00 am E.T., the company will host a conference
call to discuss its financial results and provide a company
update.
To access the call, please dial 1-888-347-7861 (domestic) or
1-412-902-4247 (international) ten minutes prior to the start
time and ask to be connected to the "Provention Bio Call." An audio
webcast will also be available on the "Events and Webcasts" page of
the Investors section of the Company's
website, www.proventionbio.com. An archived webcast will be
available on the Company's website approximately two hours after
the conference call.
About Provention Bio, Inc.:
Provention Bio, Inc.
(Nasdaq: PRVB) is a biopharmaceutical company focused on advancing
the development of investigational therapies that may intercept and
prevent debilitating and life-threatening immune-mediated disease.
The Company's pipeline includes clinical-stage product candidates
that have demonstrated in pre-clinical or clinical studies
proof-of-mechanism and/or proof-of-concept in autoimmune diseases,
including type 1 diabetes, celiac disease, and lupus. Visit
www.proventionbio.com for more information and follow us on
Twitter: @ProventionBio.
Internet Posting of Information:
Provention Bio, Inc. uses its website, www.proventionbio.com,
as a means of disclosing material nonpublic information and for
complying with its disclosure obligations under Regulation FD. Such
disclosures will be included on the Company's website in the "News"
section. Accordingly, investors should monitor this portion of the
Company's website, in addition to following its press
releases, SEC filings and public conference calls and
webcasts.
Investor Contact:
Robert
Doody, VP of Investor Relations
rdoody@proventionbio.com
484-639-7235
View original content to download
multimedia:https://www.prnewswire.com/news-releases/provention-bio-to-report-first-quarter-2022-financial-results-on-may-5-2022-301534241.html
SOURCE Provention Bio, Inc.